UY34115A - Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo - Google Patents

Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo

Info

Publication number
UY34115A
UY34115A UY0001034115A UY34115A UY34115A UY 34115 A UY34115 A UY 34115A UY 0001034115 A UY0001034115 A UY 0001034115A UY 34115 A UY34115 A UY 34115A UY 34115 A UY34115 A UY 34115A
Authority
UY
Uruguay
Prior art keywords
oxidasa
lisil
test
employment methods
employment
Prior art date
Application number
UY0001034115A
Other languages
English (en)
Inventor
Smith Victoria
Joanne I Adamkewicz
Susan K Lyman
Chien Jason
Li Xiaoming
Shao Lixin
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34115(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of UY34115A publication Critical patent/UY34115A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)

Abstract

La presente descripción proporciona un ensayo para detectar y/o cuantificar polipéptidos lisil oxidasa-like 2 (LOXL2) circulantes en un individuo. El ensayo es útil en aplicaciones diagnósticas y pronósticas, que también se proporcionan
UY0001034115A 2011-06-01 2012-06-01 Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo UY34115A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
UY34115A true UY34115A (es) 2013-01-03

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034115A UY34115A (es) 2011-06-01 2012-06-01 Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo

Country Status (24)

Country Link
US (3) US20120309020A1 (es)
EP (1) EP2714744A1 (es)
JP (3) JP2014523521A (es)
KR (1) KR20140048156A (es)
CN (1) CN103946241A (es)
AP (1) AP2013007285A0 (es)
AR (1) AR086657A1 (es)
AU (2) AU2012261883A1 (es)
BR (1) BR112013030682A2 (es)
CA (1) CA2837534A1 (es)
CL (1) CL2013003445A1 (es)
CO (1) CO6940375A2 (es)
CR (1) CR20130657A (es)
EA (1) EA201391627A1 (es)
EC (1) ECSP13013092A (es)
IL (1) IL229631A0 (es)
MA (1) MA35212B1 (es)
MD (1) MD20130098A2 (es)
MX (1) MX2013013905A (es)
PE (1) PE20141450A1 (es)
TW (1) TW201319572A (es)
UY (1) UY34115A (es)
WO (1) WO2012167181A1 (es)
ZA (1) ZA201308812B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2402334T3 (es) 2007-08-02 2013-04-30 Gilead Biologics, Inc Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
AU2010284036B2 (en) 2009-08-21 2014-12-18 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and LOXL2
MX2012009088A (es) 2010-02-04 2012-12-05 Gilead Biologics Inc Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
SG10201703240RA (en) * 2012-10-30 2017-06-29 Gilead Sciences Inc Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
US20150361182A1 (en) * 2014-06-11 2015-12-17 Gilead Sciences, Inc. Methods for treating cardiovascular diseases
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
WO2017152062A1 (en) 2016-03-04 2017-09-08 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
CA3019003A1 (en) 2016-04-08 2017-10-12 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) * 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
WO2023091479A1 (en) * 2021-11-17 2023-05-25 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2402334T3 (es) * 2007-08-02 2013-04-30 Gilead Biologics, Inc Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
CA2771786A1 (en) * 2009-08-21 2011-02-24 Gilead Biologics, Inc. In vivo screening assays
MX2012009088A (es) * 2010-02-04 2012-12-05 Gilead Biologics Inc Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
CN103946241A (zh) 2014-07-23
US20170269085A1 (en) 2017-09-21
WO2012167181A1 (en) 2012-12-06
AP2013007285A0 (en) 2013-11-30
KR20140048156A (ko) 2014-04-23
JP2018049033A (ja) 2018-03-29
AU2012261883A1 (en) 2013-05-02
NZ618682A (en) 2016-04-29
CL2013003445A1 (es) 2014-07-25
AR086657A1 (es) 2014-01-15
JP2016164578A (ja) 2016-09-08
AU2016244254B2 (en) 2018-10-18
PE20141450A1 (es) 2014-11-06
MD20130098A2 (ro) 2014-06-30
AU2016244254A1 (en) 2016-11-03
TW201319572A (zh) 2013-05-16
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CR20130657A (es) 2014-05-16
CO6940375A2 (es) 2014-05-09
US20140206017A1 (en) 2014-07-24
ZA201308812B (en) 2014-08-27
IL229631A0 (en) 2014-01-30
CA2837534A1 (en) 2012-12-06
EA201391627A1 (ru) 2014-08-29
MX2013013905A (es) 2014-05-14
US20120309020A1 (en) 2012-12-06
ECSP13013092A (es) 2014-08-29
BR112013030682A2 (pt) 2016-12-06
JP2014523521A (ja) 2014-09-11

Similar Documents

Publication Publication Date Title
UY34115A (es) Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo
UY33946A (es) Derivados de c4-monometil triterpenoides y sus métodos de uso
CL2016001432A1 (es) Nuevos anticuerpos anti-dpep3 y métodos de uso
UY34764A (es) Derivados de 2,2-difluoropropionamida de metilo de bardoxolona, formas polimórficas y sus métodos de uso
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
UY34271A (es) Anticuerpos anti-tie2 y usos de los mismos
UY34876A (es) Anticuerpos anti-egfr y usos de los mismos
ECSP14033037A (es) Síntesis de compuestos heterocíclicos
CL2015003441A1 (es) Composiciones de arní de serpina1 y sus métodos de uso
UY34538A (es) Heteroarilos y usos de los mismos
UY34683A (es) Esteviol glucosiltransferasas y genes que las codifican
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34815A (es) Anticuerpos biespecíficos y sus métodos de uso
ECSP13012786A (es) Anticuerpos anti-pcsk9 y métodos de uso
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
UY4175Q (es) Reloj pulsera
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
UY34636A (es) Composiciones tópicas que comprenden fipronilo y permetrina y sus métodos de uso
UY33930A (es) Inhibidores novedosos de quinasas
UY34119A (es) Montaje machihembrado de fijación
UY34406A (es) Compuestos y métodos para mejorar la respuesta inmune innata

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201020